Evaluation of Systemic Risk Factors in Patients with Diabetes Mellitus for Detecting Diabetic Retinopathy with Random Forest Classification Model

Author:

Venkatesh Ramesh1ORCID,Gandhi Priyanka1,Choudhary Ayushi1ORCID,Kathare Rupal1,Chhablani Jay2ORCID,Prabhu Vishma1,Bavaskar Snehal1,Hande Prathiba1,Shetty Rohit3,Reddy Nikitha Gurram4,Rani Padmaja Kumari4ORCID,Yadav Naresh Kumar1

Affiliation:

1. Department of Retina and Vitreous, Narayana Nethralaya, Bengaluru 560010, India

2. Medical Retina and Vitreoretinal Surgery, University of Pittsburgh School of Medicine, Pittsburg, PA 15213, USA

3. Department of Cornea and Refractive Services, Narayana Nethralaya, Bengaluru 560010, India

4. Anant Bajaj Retina Institute, L V Prasad Eye Institute, Kallam Anji Reddy Campus, Hyderabad 500034, India

Abstract

Background: This study aims to assess systemic risk factors in diabetes mellitus (DM) patients and predict diabetic retinopathy (DR) using a Random Forest (RF) classification model. Methods: We included DM patients presenting to the retina clinic for first-time DR screening. Data on age, gender, diabetes type, treatment history, DM control status, family history, pregnancy history, and systemic comorbidities were collected. DR and sight-threatening DR (STDR) were diagnosed via a dilated fundus examination. The dataset was split 80:20 into training and testing sets. The RF model was trained to detect DR and STDR separately, and its performance was evaluated using misclassification rates, sensitivity, and specificity. Results: Data from 1416 DM patients were analyzed. The RF model was trained on 1132 (80%) patients. The misclassification rates were 0% for DR and ~20% for STDR in the training set. External testing on 284 (20%) patients showed 100% accuracy, sensitivity, and specificity for DR detection. For STDR, the model achieved 76% (95% CI-70.7%–80.7%) accuracy, 53% (95% CI-39.2%–66.6%) sensitivity, and 80% (95% CI-74.6%–84.7%) specificity. Conclusions: The RF model effectively predicts DR in DM patients using systemic risk factors, potentially reducing unnecessary referrals for DR screening. However, further validation with diverse datasets is necessary to establish its reliability for clinical use.

Publisher

MDPI AG

Reference36 articles.

1. International Diabetes Federation (2023, November 15). IDF Diabetes Atlas [Internet]. Available online: https://diabetesatlas.org/#:~:text=diabetes%20around%20the%20world%20in%202021%3A,%2D%20and%20middle%2Dincome%20countries.

2. Magliano, D., and Boyko IDF Diabetes Atlas 10th Edition Scientific Committee (2024, May 15). IDF DIABETES ATLAS [Internet]. 10th Edition. Brussels: International Diabetes Federation; 2021. Table 3.4, Top 10 Countries or Territories for Number of Adults (20–79 Years) with Diabetes in 2021 and 2045. Available online: https://diabetesatlas.org/resources/?gad_source=1&gclid=Cj0KCQjw5ea1BhC6ARIsAEOG5pwv-AdIEEjaGvfZMSsofVibqIgrqdYkn6fYIW39tONnvGDW2ap6yv0aAhgpEALw_wcB.

3. Ocular Complications of Diabetes Mellitus;Sayin;WJD,2015

4. Vieira-Potter, V.J., Karamichos, D., and Lee, D.J. (2016). Ocular Complications of Diabetes and Therapeutic Approaches. BioMed Res. Int., 2016.

5. Diabetic Retinopathy: A Position Statement by the American Diabetes Association;Solomon;Diabetes Care,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3